Hims & Hers Health (HIMS) Total Liabilities (2019 - 2026)
Hims & Hers Health (HIMS) reported Total Liabilities of $1.8 billion for Q1 2026, up 431.72% on a YoY basis from $342.4 million in Q1 2025, and up 12.83% sequentially from $1.6 billion in Q4 2025.
Hims & Hers Health (HIMS) Total Liabilities (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Total Liabilities data on file, last reported at $1.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 431.72% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 431.72% YoY), and the FY2025 full-year result was $1.6 billion, up 599.14% from the prior year.
- Total Liabilities rose to $1.8 billion in Q1 2026, from $1.6 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.8 billion in Q1 2026 to a low of $54.3 million in Q1 2022.
- A 5-year average of $465.7 million and a median of $103.6 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities slumped 36.49% in 2022 and jumped 1009.29% in 2025, its largest moves.
- Tracing HIMS's Total Liabilities over 5 years: stood at $54.6 million in 2022, then jumped by 77.94% to $97.2 million in 2023, then soared by 137.58% to $230.8 million in 2024, then soared by 599.14% to $1.6 billion in 2025, then advanced by 12.83% to $1.8 billion in 2026.
- Business Quant data shows HIMS's Total Liabilities at $1.8 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 813.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 21.08 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.65 Bn |
| Jun 30, 2025 | 1.31 Bn |
| Mar 31, 2025 | 342.45 Mn |
| Dec 31, 2024 | 230.82 Mn |
| Sep 30, 2024 | 162.21 Mn |
| Jun 30, 2024 | 118.53 Mn |
| Mar 31, 2024 | 103.62 Mn |
| Dec 31, 2023 | 97.16 Mn |
| Sep 30, 2023 | 85.30 Mn |
| Jun 30, 2023 | 69.81 Mn |
| Mar 31, 2023 | 63.56 Mn |
| Dec 31, 2022 | 54.60 Mn |
| Sep 30, 2022 | 71.88 Mn |
| Jun 30, 2022 | 60.91 Mn |
| Mar 31, 2022 | 54.32 Mn |
| Dec 31, 2021 | 85.97 Mn |
| Sep 30, 2021 | 64.92 Mn |
| Jun 30, 2021 | 54.65 Mn |